References
Appendino G, De Petrocellis L, Trevisani M, Minassi A, Daddario N, Moriello AS, Gazzieri D, Ligresti A, Campi B, Fontana G, Pinna C, Geppetti P, Di Marzo V (2005) Development of the first ultra-potent “capsaicinoid” agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential. J Pharmacol Exp Ther 312:561–570
Avelino A, Cruz F (2006) TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. Naunyn-Schmiedeberg’s Arch Pharmacol DOI 10.1007/S00210-006-0073-2
Chubanov V, Mederos y Schnitzler M, Wäring J, Plank A, Gudermann T (2005) Emerging roles of TRPM6/TRPM7 channels kinase signal transduction complexes. Naunyn-Schmiedeberg’s Arch Pharmacol 371:334–341
Dietrich A, Mederos y Schnitzler M, Kalwa H, Storch U, Gudermann T (2005) Functional characterization and physiological relevance of the TRPC3/6/7 subfamily of cation channels. Naunyn-Schmiedeberg’s Arch Pharmacol 371:257–265
Gosling M, Poll C, Li S (2005) TRP channels in airway smooth muscle as therapeutic targets. Naunyn-Schmiedeberg’s Arch Pharmacol 371:277–284
Groschner K, Rosker C (2005) TRPC3: a versatile transducer molecule that serves integration and diversification of cellular signals. Naunyn-Schmiedeberg’s Arch Pharmacol 371:251–256
Gudermann T, Flockerzi V (2005) TRP channels as new pharmacological targets. Naunyn-Schmiedeberg’s Arch Pharmacol 371:241–244
Harteneck C (2005) Function and pharmacology of TRPM cation channels. Naunyn-Schmiedeberg’s Arch Pharmacol 371:307–314
Heiner I, Radukina N, Eisfeld J, Kühn F, Lückhoff A (2005) Regulation of TRPM2 channels in neutrophil granulocytes by ADP-ribose: a promising pharmacological target. Naunyn-Schmiedeberg’s Arch Pharmacol 371:325–333
Lis A, Wissenbach U, Phillipp SE (2005) Transcriptional regulation and processing increase the functional variability of TRPM channels. Naunyn-Schmiedeberg’s Arch Pharmacol 371:315–324
Niemeyer BA (2005) Structure-function analysis of TRPV channels. Naunyn-Schmiedeberg’s Arch Pharmacol 371: 285–294
Plant TD, Schaefer M (2005) Receptor-operated cation channels formed by TRPC4 and TRPC5. Naunyn-Schmiedeberg’s Arch Pharmacol 371:266–276
Sahai A, Khan MS, Arya M, John J, Singh R, Patel HRH (2006) The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics. Exp Opin Pharmacother 7:529–538
Szallasi A (2006) Small molecule vanilloid TRPV1 receptor ligands approaching drug status: can they live up to the expectations? Naunyn-Schmiedeberg’s Arch Pharmacol DOI 10.1007/s00210-006-0072-3
van Abel M, Hoendrop JGJ, Bindels RJM (2005) The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease. Naunyn-Schmiedeberg’s Arch Pharmacol 371:295–306
Zufall F (2005) The TRPC2 ion channel and pheromone sensing in the accessory olfactory system. Naunyn-Schmiedeberg’s Arch Pharmacol 374:245–250
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Michel, M.C. Transient receptor potential (TRP) channels as drug targets. Naunyn-Schmied Arch Pharmacol 373, 271–272 (2006). https://doi.org/10.1007/s00210-006-0071-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-006-0071-4